( 0 1 0 1 O
For 1 4 1 4 O
children 5 13 5 13 O
who 14 17 14 17 O
are 18 21 18 21 O
unable 22 28 22 28 O
to 29 31 29 31 O
cooperate 32 41 32 41 O
for 42 45 42 45 O
PFTs 46 50 46 50 B-treatment
, 50 51 50 51 O
the 52 55 52 55 O
criterion 56 65 56 65 O
is 66 68 66 68 O
: 68 69 68 69 O
No 70 72 70 72 O
evidence 73 81 73 81 O
of 82 84 82 84 O
dyspnea 85 92 85 92 B-chronic_disease
at 93 95 93 95 O
rest 96 100 96 100 O
, 100 101 100 101 O
no 102 104 102 104 O
exercise 105 113 105 113 O
intolerance 114 125 114 125 O
and 126 129 126 129 O
no 130 132 130 132 O
requirement 133 144 133 144 O
for 145 148 145 148 O
supplemental 149 161 149 161 B-treatment
oxygen 162 168 162 168 I-treatment
therapy 169 176 169 176 I-treatment
. 176 177 176 177 O
) 178 179 178 179 O

A 0 1 180 181 O
subject 2 9 182 189 O
will 10 14 190 194 O
not 15 18 195 198 O
be 19 21 199 201 O
excluded 22 30 202 210 O
because 31 38 211 218 O
of 39 41 219 221 O
pancytopenia 42 54 222 234 B-chronic_disease
related 55 62 235 242 O
to 63 65 243 245 O
disease 66 73 246 253 O

AST 0 3 254 257 B-clinical_variable
( 4 5 258 259 I-clinical_variable
SGOT)/ALT 5 14 259 268 I-clinical_variable
( 15 16 269 270 I-clinical_variable
SGPT 16 20 270 274 I-clinical_variable
) 20 21 274 275 I-clinical_variable

Absolute 0 8 276 284 B-clinical_variable
neutrophil 9 19 285 295 I-clinical_variable
count 20 25 296 301 I-clinical_variable
greater 26 33 302 309 O
than 34 38 310 314 O
or 39 41 315 317 O
equal 42 47 318 323 O
to 48 50 324 326 O
750 51 54 327 330 B-lower_bound
/ 54 55 330 331 I-lower_bound
mcL 55 58 331 334 I-lower_bound

Appropriate 0 11 335 346 O
studies 12 19 347 354 O
will 20 24 355 359 O
beundertaken 25 37 360 372 O
in 38 40 373 375 O
patients 41 49 376 384 O
receiving 50 59 385 394 O
combination 60 71 395 406 O
antiretroviral 72 86 407 421 B-treatment
therapy 87 94 422 429 I-treatment
in 95 97 430 432 O
the 98 101 433 436 O
future 102 108 437 443 O
should 109 115 444 450 O
study 116 121 451 456 O
results 122 129 457 464 O
indicate 130 138 465 473 O
effectiveness 139 152 474 487 O

CD22 0 4 488 492 O
expression 5 15 493 503 O
must 16 20 504 508 O
be 21 23 509 511 O
detected 24 32 512 520 O
on 33 35 521 523 O
greater 36 43 524 531 O
than 44 48 532 536 O
15 49 51 537 539 B-lower_bound
% 51 52 539 540 I-lower_bound
of 53 55 541 543 O
the 56 59 544 547 O
malignant 60 69 548 557 O
cells 70 75 558 563 O
by 76 78 564 566 O
immunohistochemistry 79 99 567 587 B-treatment
or 100 102 588 590 O
greater 103 110 591 598 O
than 111 115 599 603 O
80 116 118 604 606 B-lower_bound
% 118 119 606 607 I-lower_bound
by 120 122 608 610 O
flow 123 127 611 615 B-treatment
cytometry 128 137 616 625 I-treatment

Circulating 0 11 626 637 B-clinical_variable
CAR 12 15 638 641 I-clinical_variable
T 16 17 642 643 I-clinical_variable
cells 18 23 644 649 I-clinical_variable
must 24 28 650 654 O
be 29 31 655 657 O
< 32 33 658 659 O
5 33 34 659 660 B-upper_bound
% 34 35 660 661 I-upper_bound
in 36 38 662 664 O
peripheral 39 49 665 675 O
blood 50 55 676 681 O

Cytopenias 0 10 682 692 B-chronic_disease
deemed 11 17 693 699 O
to 18 20 700 702 O
be 21 23 703 705 O
disease 24 31 706 713 O
- 31 32 713 714 O
related 32 39 714 721 O
and 40 43 722 725 O
not 44 47 726 729 O
therapy 48 55 730 737 O
- 55 56 737 738 O
related 56 63 738 745 O

For 0 3 746 749 O
radiation 4 13 750 759 B-treatment
therapy 14 21 760 767 I-treatment
: 21 22 767 768 O
Radiation 23 32 769 778 B-treatment
therapy 33 40 779 786 I-treatment
must 41 45 787 791 O
have 46 50 792 796 O
been 51 55 797 801 O
completed 56 65 802 811 O
at 66 68 812 814 O
least 69 74 815 820 O
3 75 76 821 822 B-lower_bound
weeks 77 82 823 828 I-lower_bound
prior 83 88 829 834 I-lower_bound
to 89 91 835 837 O
enrollment 92 102 838 848 O
( 103 104 849 850 O
including 104 113 850 859 O
CNS 114 117 860 863 B-treatment
radiation 118 127 864 873 I-treatment
) 127 128 873 874 O
, 128 129 874 875 O
with 130 134 876 880 O
the 135 138 881 884 O
exception 139 148 885 894 O
that 149 153 895 899 O
there 154 159 900 905 O
is 160 162 906 908 O
no 163 165 909 911 O
time 166 170 912 916 O
restriction 171 182 917 928 O
if 183 185 929 931 O
the 186 189 932 935 O
volume 190 196 936 942 O
of 197 199 943 945 O
bone 200 204 946 950 O
marrow 205 211 951 957 O
treated 212 219 958 965 O
is 220 222 966 968 O
less 223 227 969 973 O
than 228 232 974 978 O
10 233 235 979 981 B-upper_bound
% 235 236 981 982 I-upper_bound
and 237 240 983 986 O
also 241 245 987 991 O
the 246 249 992 995 O
subject 250 257 996 1003 O
has 258 261 1004 1007 O
measurable 262 272 1008 1018 O
/ 272 273 1018 1019 O
evaluable 273 282 1019 1028 O
disease 283 290 1029 1036 O
outside 291 298 1037 1044 O
the 299 302 1045 1048 O
radiation 303 312 1049 1058 O
port 313 317 1059 1063 O

Greater 0 7 1064 1071 O
than 8 12 1072 1076 O
or 13 15 1077 1079 O
equal 16 21 1080 1085 O
to 22 24 1086 1088 O
1 25 26 1089 1090 B-lower_bound
year 27 31 1091 1095 I-lower_bound
of 32 34 1096 1098 O
age 35 38 1099 1102 B-age
( 39 40 1103 1104 O
and 40 43 1104 1107 O
at 44 46 1108 1110 O
least 47 52 1111 1116 O
14.5 53 57 1117 1121 B-lower_bound
kg 58 60 1122 1124 I-lower_bound
) 60 61 1124 1125 O
and 62 65 1126 1129 O
less 66 70 1130 1134 O
than 71 75 1135 1139 O
or 76 78 1140 1142 O
equal 79 84 1143 1148 O
to 85 87 1149 1151 O
30 88 90 1152 1154 B-upper_bound
years 91 96 1155 1160 I-upper_bound
of 97 99 1161 1163 O
age 100 103 1164 1167 O
at 104 106 1168 1170 O
time 107 111 1171 1175 O
of 112 114 1176 1178 O
enrollment 115 125 1179 1189 O

HIV 0 3 1190 1193 B-chronic_disease
/ 3 4 1193 1194 O
HBV 4 7 1194 1197 B-chronic_disease
/ 7 8 1197 1198 O
HCV 8 11 1198 1201 B-chronic_disease
Infection 12 21 1202 1211 I-chronic_disease

Hematologic 0 11 1212 1223 B-chronic_disease
function 12 20 1224 1232 O

History 0 7 1233 1240 O
of 8 10 1241 1243 O
severe 11 17 1244 1250 O
, 17 18 1250 1251 O
immediate 19 28 1252 1261 O
hypersensitivity 29 45 1262 1278 O
reaction 46 54 1279 1287 O
attributed 55 65 1288 1298 O
to 66 68 1299 1301 O
compounds 69 78 1302 1311 O
of 79 81 1312 1314 O
similar 82 89 1315 1322 O
chemical 90 98 1323 1331 O
or 99 101 1332 1334 O
biologic 102 110 1335 1343 O
composition 111 122 1344 1355 O
to 123 125 1356 1358 O
any 126 129 1359 1362 O
agents 130 136 1363 1369 O
used 137 141 1370 1374 O
in 142 144 1375 1377 O
study 145 150 1378 1383 O
or 151 153 1384 1386 O
in 154 156 1387 1389 O
the 157 160 1390 1393 O
manufacturing 161 174 1394 1407 O
of 175 177 1408 1410 O
the 178 181 1411 1414 O
cells 182 187 1415 1420 O
( 188 189 1421 1422 O
i.e. 189 193 1422 1426 O
gentamicin 194 204 1427 1437 B-allergy_name
) 204 205 1437 1438 O

Hyperleukocytosis 0 17 1439 1456 B-cancer

In 0 2 1457 1459 O
view 3 7 1460 1464 O
of 8 10 1465 1467 O
the 11 14 1468 1471 O
PI 15 17 1472 1474 O
and 18 21 1475 1478 O
the 22 25 1479 1482 O
primary 26 33 1483 1490 O
oncologist 34 44 1491 1501 O
, 44 45 1501 1502 O
there 46 51 1503 1508 O
must 52 56 1509 1513 O
be 57 59 1514 1516 O
no 60 62 1517 1519 O
available 63 72 1520 1529 O
alternative 73 84 1530 1541 B-treatment
curative 85 93 1542 1550 I-treatment
therapies 94 103 1551 1560 I-treatment

Karnofsky 0 9 1561 1570 B-clinical_variable
greater 10 17 1571 1578 O
than 18 22 1579 1583 O
or 23 25 1584 1586 O
equal 26 31 1587 1592 O
to 32 34 1593 1595 O
50 35 37 1596 1598 B-lower_bound
% 37 38 1598 1599 I-lower_bound

Lansky 0 6 1600 1606 B-clinical_variable
scale 7 12 1607 1612 I-clinical_variable
greater 13 20 1613 1620 O
than 21 25 1621 1625 O
or 26 28 1626 1628 O
equal 29 34 1629 1634 O
to 35 37 1635 1637 O
50 38 40 1638 1640 B-lower_bound
% 40 41 1640 1641 I-lower_bound

Left 0 4 1642 1646 B-clinical_variable
ventricular 5 16 1647 1658 I-clinical_variable
ejection 17 25 1659 1667 I-clinical_variable
fraction 26 34 1668 1676 I-clinical_variable
greater 35 42 1677 1684 O
than 43 47 1685 1689 O
or 48 50 1690 1692 O
equal 51 56 1693 1698 O
to 57 59 1699 1701 O
45 60 62 1702 1704 B-lower_bound
% 62 63 1704 1705 I-lower_bound

Normal 0 6 1706 1712 B-clinical_variable
creatinineCreatinine 7 27 1713 1733 I-clinical_variable
level 28 33 1734 1739 I-clinical_variable
< 34 35 1740 1741 O
the 36 39 1742 1745 O
maximum 40 47 1746 1753 O
for 48 51 1754 1757 O
age 52 55 1758 1761 B-age

Other 0 5 1762 1767 O
anti 6 10 1768 1772 B-treatment
- 10 11 1772 1773 I-treatment
neoplastic 11 21 1773 1783 I-treatment
investigational 22 37 1784 1799 I-treatment
agents 38 44 1800 1806 I-treatment
, 44 45 1806 1807 O
or 46 48 1808 1810 O
antibody 49 57 1811 1819 O
based 58 63 1820 1825 O
therapies 64 73 1826 1835 B-treatment
currently 74 83 1836 1845 O
or 84 86 1846 1848 O
within 87 93 1849 1855 O
2 94 95 1856 1857 B-upper_bound
weeks 96 101 1858 1863 I-upper_bound
prior 102 107 1864 1869 I-upper_bound
to 108 110 1870 1872 O
apheresis 111 120 1873 1882 O

Patient 0 7 1883 1890 O
must 8 12 1891 1895 O
have 13 17 1896 1900 O
a 18 19 1901 1902 O
B 20 21 1903 1904 B-cancer
cell 22 26 1905 1909 I-cancer
ALL 27 30 1910 1913 I-cancer
( 31 32 1914 1915 O
inclusive 32 41 1915 1924 O
of 42 44 1925 1927 O
ALL 45 48 1928 1931 O
blast 49 54 1932 1937 O
transformation 55 69 1938 1952 O
from 70 74 1953 1957 O
CML 75 78 1958 1961 O
) 78 79 1961 1962 O
or 80 82 1963 1965 O
lymphoma 83 91 1966 1974 B-cancer

Patients 0 8 1975 1983 O
< 9 10 1984 1985 O
16 11 13 1986 1988 B-upper_bound
years 14 19 1989 1994 I-upper_bound
of 20 22 1995 1997 O
age 23 26 1998 2001 B-age

Patients 0 8 2002 2010 O
greater 9 16 2011 2018 O
than 17 21 2019 2023 O
or 22 24 2024 2026 O
equal 25 30 2027 2032 O
to 31 33 2033 2035 O
16 34 36 2036 2038 B-lower_bound
years 37 42 2039 2044 I-lower_bound
of 43 45 2045 2047 O
age 46 49 2048 2051 B-age

Patients 0 8 2052 2060 O
must 9 13 2061 2065 O
have 14 18 2066 2070 O
measurable 19 29 2071 2081 O
or 30 32 2082 2084 O
evaluable 33 42 2085 2094 O
disease 43 50 2095 2102 O
at 51 53 2103 2105 O
the 54 57 2106 2109 O
time 58 62 2110 2114 O
of 63 65 2115 2117 O
enrollment 66 76 2118 2128 O
, 76 77 2128 2129 O
which 78 83 2130 2135 O
may 84 87 2136 2139 O
include 88 95 2140 2147 O
any 96 99 2148 2151 O
evidence 100 108 2152 2160 O
of 109 111 2161 2163 O
disease 112 119 2164 2171 O
including 120 129 2172 2181 O
minimal 130 137 2182 2189 B-cancer
residual 138 146 2190 2198 I-cancer
disease 147 154 2199 2206 I-cancer
detected 155 163 2207 2215 O
by 164 166 2216 2218 O
flow 167 171 2219 2223 B-treatment
cytometry 172 181 2224 2233 I-treatment
, 181 182 2233 2234 O
cytogenetics 183 195 2235 2247 B-treatment
, 195 196 2247 2248 O
or 197 199 2249 2251 O
polymerase 200 210 2252 2262 B-treatment
chain 211 216 2263 2268 I-treatment
reaction 217 225 2269 2277 I-treatment
( 226 227 2278 2279 I-treatment
PCR 227 230 2279 2282 I-treatment
) 230 231 2282 2283 I-treatment
analysis 232 240 2284 2292 O

Patients 0 8 2293 2301 O
of 9 11 2302 2304 O
child 12 17 2305 2310 O
- 17 18 2310 2311 O
bearing 18 25 2311 2318 O
or 26 28 2319 2321 O
child 29 34 2322 2327 O
- 34 35 2327 2328 O
fathering 35 44 2328 2337 O
potential 45 54 2338 2347 O
must 55 59 2348 2352 O
be 60 62 2353 2355 O
willing 63 70 2356 2363 B-contraception_consent
to 71 73 2364 2366 I-contraception_consent
practice 74 82 2367 2375 I-contraception_consent
birth 83 88 2376 2381 I-contraception_consent
control 89 96 2382 2389 I-contraception_consent
from 97 101 2390 2394 O
the 102 105 2395 2398 O
time 106 110 2399 2403 O
of 111 113 2404 2406 O
enrollment 114 124 2407 2417 O
on 125 127 2418 2420 O
this 128 132 2421 2425 O
study 133 138 2426 2431 O
and 139 142 2432 2435 O
for 143 146 2436 2439 O
four 147 151 2440 2444 B-upper_bound
months 152 158 2445 2451 I-upper_bound
after 159 164 2452 2457 I-upper_bound
receiving 165 174 2458 2467 O
the 175 178 2468 2471 O
preparative 179 190 2472 2483 B-treatment
regimen 191 198 2484 2491 I-treatment

Patients 0 8 2492 2500 O
who 9 12 2501 2504 O
are 13 16 2505 2508 O
on 17 19 2509 2511 O
standard 20 28 2512 2520 O
ALL 29 32 2521 2524 O
maintenance 33 44 2525 2536 O
type 45 49 2537 2541 O
chemotherapy 50 62 2542 2554 B-treatment
( 63 64 2555 2556 O
vincristine 64 75 2556 2567 B-treatment
, 75 76 2567 2568 O
6- 77 79 2569 2571 B-treatment
mercaptopurine 80 94 2572 2586 I-treatment
, 94 95 2586 2587 O
oral 96 100 2588 2592 B-treatment
methotrexate 101 113 2593 2605 I-treatment
, 113 114 2605 2606 O
or 115 117 2607 2609 O
a 118 119 2610 2611 O
tyrosine 120 128 2612 2620 B-treatment
kinase 129 135 2621 2627 I-treatment
inhibitor 136 145 2628 2637 I-treatment
for 146 149 2638 2641 O
patients 150 158 2642 2650 O
with 159 163 2651 2655 O
Ph+ 164 167 2656 2659 B-cancer
ALL 168 171 2660 2663 I-cancer
) 171 172 2663 2664 O
may 173 176 2665 2668 O
be 177 179 2669 2671 O
enrolled 180 188 2672 2680 O
provided 189 197 2681 2689 O
that 198 202 2690 2694 O
chemotherapy 203 215 2695 2707 O
is 216 218 2708 2710 O
discontinued 219 231 2711 2723 O
at 232 234 2724 2726 O
least 235 240 2727 2732 O
1 241 242 2733 2734 B-lower_bound

Patients 0 8 2735 2743 O
with 9 13 2744 2748 O
HIV 14 17 2749 2752 B-chronic_disease
are 18 21 2753 2756 O
at 22 24 2757 2759 O
increased 25 34 2760 2769 O
risk 35 39 2770 2774 O
of 40 42 2775 2777 O
lethal 43 49 2778 2784 B-chronic_disease
infections 50 60 2785 2795 I-chronic_disease
when 61 65 2796 2800 O
treated 66 73 2801 2808 O
with 74 78 2809 2813 O
marrow 79 85 2814 2820 B-treatment
- 85 86 2820 2821 I-treatment
suppressive 86 97 2821 2832 I-treatment
therapy 98 105 2833 2840 I-treatment

Patients 0 8 2841 2849 O
without 9 16 2850 2857 O
respiratory 17 28 2858 2869 B-chronic_disease
symptoms 29 37 2870 2878 I-chronic_disease
( 38 39 2879 2880 O
e.g. 39 43 2880 2884 O
dyspnea 44 51 2885 2892 O
at 52 54 2893 2895 O
rest 55 59 2896 2900 O
, 59 60 2900 2901 O
known 61 66 2902 2907 O
requirement 67 78 2908 2919 O
for 79 82 2920 2923 O
supplemental 83 95 2924 2936 O
oxygen 96 102 2937 2943 B-treatment
therapy 103 110 2944 2951 I-treatment
) 110 111 2951 2952 O

Pediatric 0 9 2953 2962 O
subjects 10 18 2963 2971 O
will 19 23 2972 2976 O
be 24 26 2977 2979 O
included 27 35 2980 2988 O
in 36 38 2989 2991 O
age 39 42 2992 2995 B-age
appropriate 43 54 2996 3007 O
discussion 55 65 3008 3018 O
and 66 69 3019 3022 O
verbal 70 76 3023 3029 O
assent 77 83 3030 3036 O
will 84 88 3037 3041 O
be 89 91 3042 3044 O
obtained 92 100 3045 3053 O
for 101 104 3054 3057 O
those 105 110 3058 3063 O
> 111 112 3064 3065 O
7 113 114 3066 3067 B-lower_bound
years 115 120 3068 3073 I-lower_bound
of 121 123 3074 3076 O
age 124 127 3077 3080 O
, 127 128 3080 3081 O
when 129 133 3082 3086 O
appropriate 134 145 3087 3098 O

Platelets 0 9 3099 3108 B-clinical_variable
greater 10 17 3109 3116 O
than 18 22 3117 3121 O
or 23 25 3122 3124 O
equal 26 31 3125 3130 O
to 32 34 3131 3133 O
50,000 35 41 3134 3140 B-lower_bound
/ 41 42 3140 3141 I-lower_bound
mcl 42 45 3141 3144 I-lower_bound

Pregnant 0 8 3145 3153 B-pregnancy

Prior 0 5 3154 3159 B-treatment
CAR 6 9 3160 3163 I-treatment
therapy 10 17 3164 3171 I-treatment
within 18 24 3172 3178 O
30 25 27 3179 3181 B-upper_bound
days 28 32 3182 3186 I-upper_bound
prior 33 38 3187 3192 I-upper_bound
to 39 41 3193 3195 O
apheresis 42 51 3196 3205 B-treatment
or 52 54 3206 3208 O
prior 55 60 3209 3214 B-treatment
CAR 61 64 3215 3218 I-treatment
therapy 65 72 3219 3226 I-treatment
at 73 75 3227 3229 O
any 76 79 3230 3233 O
time 80 84 3234 3238 O
with 85 89 3239 3243 O
evidence 90 98 3244 3252 O
for 99 102 3253 3256 O
persistence 103 114 3257 3268 O
of 115 117 3269 3271 O
CAR 118 121 3272 3275 B-clinical_variable
T 122 123 3276 3277 I-clinical_variable
cells 124 129 3278 3283 I-clinical_variable
in 130 132 3284 3286 O
blood 133 138 3287 3292 O
samples 139 146 3293 3300 O
( 147 148 3301 3302 O
circulating 148 159 3302 3313 O
levels 160 166 3314 3320 O
of 167 169 3321 3323 O
genetically 170 181 3324 3335 O
modified 182 190 3336 3344 O
cells 191 196 3345 3350 O
of 197 199 3351 3353 O
greater 200 207 3354 3361 O
than 208 212 3362 3366 O
or 213 215 3367 3369 O
equal 216 221 3370 3375 O
to 222 224 3376 3378 O
5 225 226 3379 3380 B-lower_bound
% 226 227 3380 3381 I-lower_bound
by 228 230 3382 3384 O
flow 231 235 3385 3389 B-treatment
cytometry 236 245 3390 3399 I-treatment
) 245 246 3399 3400 O

Second 0 6 3401 3407 B-cancer
malignancy 7 17 3408 3418 I-cancer
other 18 23 3419 3424 O
than 24 28 3425 3429 O
in 29 31 3430 3432 O
situ 32 36 3433 3437 B-cancer
carcinoma 37 46 3438 3447 I-cancer
of 47 49 3448 3450 I-cancer
the 50 53 3451 3454 I-cancer
cervix 54 60 3455 3461 I-cancer
, 60 61 3461 3462 O
unless 62 68 3463 3469 O
the 69 72 3470 3473 O
tumor 73 78 3474 3479 B-cancer
was 79 82 3480 3483 O
treated 83 90 3484 3491 O
with 91 95 3492 3496 O
curative 96 104 3497 3505 O
intent 105 111 3506 3512 O
at 112 114 3513 3515 O
least 115 120 3516 3521 O
two 121 124 3522 3525 B-lower_bound
years 125 130 3526 3531 I-lower_bound
previously 131 141 3532 3542 O
and 142 145 3543 3546 O
subject 146 153 3547 3554 O
is 154 156 3555 3557 O
in 157 159 3558 3560 O
remission 160 169 3561 3570 O

Seropositive 0 12 3571 3583 O
for 13 16 3584 3587 O
HIV 17 20 3588 3591 B-chronic_disease
antibody 21 29 3592 3600 I-chronic_disease

Seropositive 0 12 3601 3613 O
for 13 16 3614 3617 O
hepatitis 17 26 3618 3627 B-chronic_disease
C 27 28 3628 3629 I-chronic_disease
or 29 31 3630 3632 O
positive 32 40 3633 3641 O
for 41 44 3642 3645 O
Hepatitis 45 54 3646 3655 B-chronic_disease
B 55 56 3656 3657 I-chronic_disease
surface 57 64 3658 3665 I-chronic_disease
antigen 65 72 3666 3673 I-chronic_disease
( 73 74 3674 3675 I-chronic_disease
HbsAG 74 79 3675 3680 I-chronic_disease
) 79 80 3680 3681 I-chronic_disease

Subjects 0 8 3682 3690 O
must 9 13 3691 3695 O
have 14 18 3696 3700 O
recovered 19 28 3701 3710 O
from 29 33 3711 3715 O
the 34 37 3716 3719 O
acute 38 43 3720 3725 O
side 44 48 3726 3730 O
effects 49 56 3731 3738 O
of 57 59 3739 3741 O
their 60 65 3742 3747 O
prior 66 71 3748 3753 B-treatment
therapy 72 79 3754 3761 I-treatment
, 79 80 3761 3762 O
such 81 85 3763 3767 O
that 86 90 3768 3772 O
eligibility 91 102 3773 3784 O
criteria 103 111 3785 3793 O
are 112 115 3794 3797 O
met 116 119 3798 3801 O

Subjects 0 8 3802 3810 O
receiving 9 18 3811 3820 O
hydroxyurea 19 30 3821 3832 B-treatment
may 31 34 3833 3836 O
be 35 37 3837 3839 O
enrolled 38 46 3840 3848 O
provided 47 55 3849 3857 O
there 56 61 3858 3863 O
has 62 65 3864 3867 O
been 66 70 3868 3872 O
no 71 73 3873 3875 O
increase 74 82 3876 3884 O
in 83 85 3885 3887 O
dose 86 90 3888 3892 O
for 91 94 3893 3896 O
at 95 97 3897 3899 O
least 98 103 3900 3905 O
2 104 105 3906 3907 B-lower_bound
weeks 106 111 3908 3913 I-lower_bound
prior 112 117 3914 3919 I-lower_bound
to 118 120 3920 3922 O
starting 121 129 3923 3931 O
apheresis 130 139 3932 3941 B-treatment

Subjects 0 8 3942 3950 O
receiving 9 18 3951 3960 O
steroids 19 27 3961 3969 B-treatment
may 28 31 3970 3973 O
be 32 34 3974 3976 O
enrolled 35 43 3977 3985 O
, 43 44 3985 3986 O
provided 45 53 3987 3995 O
there 54 59 3996 4001 O
has 60 63 4002 4005 O
been 64 68 4006 4010 O
no 69 71 4011 4013 O
increase 72 80 4014 4022 O
in 81 83 4023 4025 O
dose 84 88 4026 4030 O
for 89 92 4031 4034 O
at 93 95 4035 4037 O
least 96 101 4038 4043 O
1 102 103 4044 4045 B-lower_bound
week 104 108 4046 4050 I-lower_bound
prior 109 114 4051 4056 I-lower_bound
to 115 117 4057 4059 O
starting 118 126 4060 4068 O
apheresis 127 136 4069 4078 B-treatment

Subjects 0 8 4079 4087 O
with 9 13 4088 4092 O
CNS 14 17 4093 4096 B-chronic_disease
disease 18 25 4097 4104 I-chronic_disease

Subjects 0 8 4105 4113 O
with 9 13 4114 4118 O
radiologically 14 28 4119 4133 O
- 28 29 4133 4134 O
detected 29 37 4134 4142 O
active 38 44 4143 4149 O
CNS 45 48 4150 4153 B-cancer
lymphoma 49 57 4154 4162 I-cancer
, 57 58 4162 4163 O
leptomeningeal 59 73 4164 4178 B-cancer
CNS 74 77 4179 4182 I-cancer
disease 78 85 4183 4190 I-cancer
or 86 88 4191 4193 O
isolated 89 97 4194 4202 O
CNS 98 101 4203 4206 O
disease 102 109 4207 4214 O
which 110 115 4215 4220 O
are 116 119 4221 4224 O
eligible 120 128 4225 4233 O
for 129 132 4234 4237 O
definitive 133 143 4238 4248 O
CNS 144 147 4249 4252 O
directed 148 156 4253 4261 O
radiationtherapy 157 173 4262 4278 B-treatment

Systemic 0 8 4279 4287 B-treatment
chemotherapy 9 21 4288 4300 I-treatment
2 22 23 4301 4302 B-upper_bound
weeks 24 29 4303 4308 I-upper_bound
( 30 31 4309 4310 O
6 31 32 4310 4311 B-upper_bound
weeks 33 38 4312 4317 I-upper_bound
for 39 42 4318 4321 O
clofarabine 43 54 4322 4333 B-treatment
or 55 57 4334 4336 O
nitrosoureas 58 70 4337 4349 B-treatment
) 70 71 4349 4350 O

The 0 3 4351 4354 O
choice 4 10 4355 4361 O
of 11 13 4362 4364 O
whether 14 21 4365 4372 O
to 22 24 4373 4375 O
use 25 28 4376 4379 O
flow 29 33 4380 4384 B-clinical_variable
cytometry 34 43 4385 4394 I-clinical_variable
or 44 46 4395 4397 O
immunohistochemistry 47 67 4398 4418 O
will 68 72 4419 4423 O
be 73 75 4424 4426 O
determined 76 86 4427 4437 O
by 87 89 4438 4440 O
what 90 94 4441 4445 O
is 95 97 4446 4448 O
the 98 101 4449 4452 O
most 102 106 4453 4457 O
easily 107 113 4458 4464 O
available 114 123 4465 4474 O
tissue 124 130 4475 4481 O
sample 131 137 4482 4488 O
in 138 140 4489 4491 O
each 141 145 4492 4496 O
patent 146 152 4497 4503 O

There 0 5 4504 4509 O
is 6 8 4510 4512 O
no 9 11 4513 4515 O
time 12 16 4516 4520 O
restriction 17 28 4521 4532 O
in 29 31 4533 4535 O
regard 32 38 4536 4542 O
to 39 41 4543 4545 O
prior 42 47 4546 4551 B-treatment
intrathecal 48 59 4552 4563 I-treatment
chemotherapy 60 72 4564 4576 I-treatment
provided 73 81 4577 4585 O
there 82 87 4586 4591 O
is 88 90 4592 4594 O
complete 91 99 4595 4603 O
recovery 100 108 4604 4612 O
from 109 113 4613 4617 O
any 114 117 4618 4621 O
acute 118 123 4622 4627 O
toxic 124 129 4628 4633 O
effects 130 137 4634 4641 O

Total 0 5 4642 4647 B-clinical_variable
bilirubin 6 15 4648 4657 I-clinical_variable
less 16 20 4658 4662 O
than 21 25 4663 4667 O
or 26 28 4668 4670 O
equal 29 34 4671 4676 O
to 35 37 4677 4679 O
2 38 39 4680 4681 B-upper_bound
x 40 41 4682 4683 I-upper_bound
ULN 42 45 4684 4687 I-upper_bound

Uncontrolled 0 12 4688 4700 O
, 12 13 4700 4701 O
symptomatic 14 25 4702 4713 O
, 25 26 4713 4714 O
intercurrent 27 39 4715 4727 B-chronic_disease
illness 40 47 4728 4735 I-chronic_disease
including 48 57 4736 4745 O
but 58 61 4746 4749 O
not 62 65 4750 4753 O
limited 66 73 4754 4761 O
to 74 76 4762 4764 O
infection 77 86 4765 4774 B-chronic_disease
, 86 87 4774 4775 O
congestive 88 98 4776 4786 B-chronic_disease
heart 99 104 4787 4792 I-chronic_disease
failure 105 112 4793 4800 I-chronic_disease
, 112 113 4800 4801 O
unstable 114 122 4802 4810 B-chronic_disease
angina 123 129 4811 4817 I-chronic_disease
pectoris 130 138 4818 4826 I-chronic_disease
, 138 139 4826 4827 O
cardiac 140 147 4828 4835 B-chronic_disease
arrhythmia 148 158 4836 4846 I-chronic_disease
, 158 159 4846 4847 O
psychiatric 160 171 4848 4859 B-chronic_disease
illness 172 179 4860 4867 I-chronic_disease
, 179 180 4867 4868 O
or 181 183 4869 4871 O
social 184 190 4872 4878 B-chronic_disease
situations 191 201 4879 4889 I-chronic_disease
that 202 206 4890 4894 O
would 207 212 4895 4900 O
limit 213 218 4901 4906 O
compliance 219 229 4907 4917 O
with 230 234 4918 4922 O
study 235 240 4923 4928 O
requirements 241 253 4929 4941 O
or 254 256 4942 4944 O
in 257 259 4945 4947 O
the 260 263 4948 4951 O
opinion 264 271 4952 4959 O
of 272 274 4960 4962 O
the 275 278 4963 4966 O
PI 279 281 4967 4969 O
would 282 287 4970 4975 O
pose 288 292 4976 4980 O
an 293 295 4981 4983 O
unacceptable 296 308 4984 4996 O
risk 309 313 4997 5001 O
to 314 316 5002 5004 O
the 317 320 5005 5008 O
subject 321 328 5009 5016 O

between 0 7 5017 5024 O
6 8 9 5025 5026 B-lower_bound
and 10 13 5027 5030 O
10 14 16 5031 5033 B-upper_bound
years 17 22 5034 5039 I-upper_bound
old 23 26 5040 5043 O

breast 0 6 5044 5050 O
- 6 7 5050 5051 O
feeding 7 14 5051 5058 O
females 15 22 5059 5066 B-gender

creatinine 0 10 5067 5077 B-clinical_variable
clearance 11 20 5078 5087 I-clinical_variable
greater 21 28 5088 5095 O
than 29 33 5096 5100 O
or 34 36 5101 5103 O
equal 37 42 5104 5109 O
to 43 45 5110 5112 O
60 46 48 5113 5115 B-lower_bound
mL 49 51 5116 5118 I-lower_bound
/ 51 52 5118 5119 I-lower_bound
min/1.73 52 60 5119 5127 I-lower_bound
m2 61 63 5128 5130 I-lower_bound
for 64 67 5131 5134 O
patients 68 76 5135 5143 O
with 77 81 5144 5148 O
creatinine 82 92 5149 5159 B-clinical_variable
levels 93 99 5160 5166 I-clinical_variable
above 100 105 5167 5172 O
institutional 106 119 5173 5186 O
normal 120 126 5187 5193 O

fractional 0 10 5194 5204 B-clinical_variable
shortening 11 21 5205 5215 I-clinical_variable
greater 22 29 5216 5223 O
than 30 34 5224 5228 O
or 35 37 5229 5231 O
equal 38 43 5232 5237 O
to 44 46 5238 5240 O
28 47 49 5241 5243 B-lower_bound
% 49 50 5243 5244 I-lower_bound

greater 0 7 5245 5252 O
than 8 12 5253 5257 O
10 13 15 5258 5260 B-lower_bound
years 16 21 5261 5266 I-lower_bound
old 22 25 5267 5270 O

greater 0 7 5271 5278 O
than 8 12 5279 5283 O
or 13 15 5284 5286 O
equal 16 21 5287 5292 O
to 22 24 5293 5295 O
5 25 26 5296 5297 B-lower_bound
years 27 32 5298 5303 I-lower_bound
old 33 36 5304 5307 O
: 36 37 5307 5308 O
maximum 38 45 5309 5316 B-upper_bound
serum 46 51 5317 5322 I-upper_bound
creatinine 52 62 5323 5333 I-upper_bound
0.8mg 63 68 5334 5339 B-upper_bound
/ 68 69 5339 5340 I-upper_bound
dL 69 71 5340 5342 I-upper_bound

greater 0 7 5343 5350 O
than 8 12 5351 5355 O
or 13 15 5356 5358 O
equal 16 21 5359 5364 O
to 22 24 5365 5367 O
50,000 25 31 5368 5374 B-lower_bound
blasts/ 32 39 5375 5382 I-lower_bound
L 40 41 5383 5384 I-lower_bound

immunohistochemistry 0 20 5385 5405 B-treatment
will 21 25 5406 5410 O
be 26 28 5411 5413 O
used 29 33 5414 5418 O
for 34 37 5419 5422 O
lymph 38 43 5423 5428 B-treatment
node 44 48 5429 5433 I-treatment
biopsies 49 57 5434 5442 I-treatment
, 57 58 5442 5443 O
flow 59 63 5444 5448 B-treatment
cytometry 64 73 5449 5458 I-treatment
will 74 78 5459 5463 O
be 79 81 5464 5466 O
used 82 86 5467 5471 O
for 87 90 5472 5475 O
peripheral 91 101 5476 5486 O
blood 102 107 5487 5492 O
and 108 111 5493 5496 O
bone 112 116 5497 5501 O
marrow 117 123 5502 5508 O
samples 124 131 5509 5516 O
and 132 135 5517 5520 O
CSF 136 139 5521 5524 O
when 140 144 5525 5529 O
feasible 145 153 5530 5538 O

ineligible 0 10 5539 5549 O
for 11 14 5550 5553 O
allogeneic 15 25 5554 5564 B-treatment
stem 26 30 5565 5569 I-treatment
cell 31 35 5570 5574 I-treatment
transplant 36 46 5575 5585 I-treatment
( 47 48 5586 5587 I-treatment
SCT 48 51 5587 5590 I-treatment
) 51 52 5590 5591 I-treatment
, 52 53 5591 5592 O
have 54 58 5593 5597 O
refused 59 66 5598 5605 O
SCT 67 70 5606 5609 O
, 70 71 5609 5610 O
recurred 72 80 5611 5619 O
after 81 86 5620 5625 O
SCT 87 90 5626 5629 O
, 90 91 5629 5630 O
or 92 94 5631 5633 O
have 95 99 5634 5638 O
disease 100 107 5639 5646 O
activity 108 116 5647 5655 O
that 117 121 5656 5660 O
prohibits 122 131 5661 5670 O
SCT 132 135 5671 5674 O
at 136 138 5675 5677 O
the 139 142 5678 5681 O
time 143 147 5682 5686 O
of 148 150 5687 5689 O
enrollment 151 161 5690 5700 O

less 0 4 5701 5705 O
than 5 9 5706 5710 O
or 10 12 5711 5713 O
equal 13 18 5714 5719 O
to 19 21 5720 5722 O
20 22 24 5723 5725 B-upper_bound
x 25 26 5726 5727 I-upper_bound
institutional 27 40 5728 5741 I-upper_bound
upper 41 46 5742 5747 I-upper_bound
limit 47 52 5748 5753 I-upper_bound
of 53 55 5754 5756 I-upper_bound
normal 56 62 5757 5763 I-upper_bound

maximum 0 7 5764 5771 O
serum 8 13 5772 5777 B-clinical_variable
creatinine 14 24 5778 5788 I-clinical_variable
1.0mg 25 30 5789 5794 B-upper_bound
/ 30 31 5794 5795 I-upper_bound
dL 31 33 5795 5797 I-upper_bound

maximum 0 7 5798 5805 B-clinical_variable
serum 8 13 5806 5811 I-clinical_variable
creatinine 14 24 5812 5822 I-clinical_variable
1.2mg 25 30 5823 5828 B-lower_bound
/ 30 31 5828 5829 I-lower_bound
dL 31 33 5829 5831 I-lower_bound

radiation 0 9 5832 5841 B-treatment
therapy 10 17 5842 5849 I-treatment
3 18 19 5850 5851 B-upper_bound
weeks 20 25 5852 5857 I-upper_bound
prior 26 31 5858 5863 I-upper_bound
to 32 34 5864 5866 O
apheresis 35 44 5867 5876 O

relapsed 0 8 5877 5885 B-chronic_disease
or 9 11 5886 5888 I-chronic_disease
refractory 12 22 5889 5899 I-chronic_disease
disease 23 30 5900 5907 I-chronic_disease
after 31 36 5908 5913 O
at 37 39 5914 5916 O
least 40 45 5917 5922 O
one 46 49 5923 5926 B-lower_bound
standard 50 58 5927 5935 O
chemotherapy 59 71 5936 5948 B-treatment
regimen 72 79 5949 5956 I-treatment
and 80 83 5957 5960 O
one 84 87 5961 5964 O
salvage 88 95 5965 5972 O
regimen 96 103 5973 5980 O

subjects 0 8 5981 5989 O
with 9 13 5990 5994 O
documented 14 24 5995 6005 O
Gilbert 25 32 6006 6013 B-clinical_variable
s 33 34 6014 6015 I-clinical_variable
disease 35 42 6016 6023 I-clinical_variable
greater 43 50 6024 6031 O
than 51 55 6032 6036 O
or 56 58 6037 6039 O
equal 59 64 6040 6045 O
to 65 67 6046 6048 O
3 68 69 6049 6050 B-lower_bound
x 70 71 6051 6052 I-lower_bound
ULN 72 75 6053 6056 I-lower_bound

who 0 3 6057 6060 O
have 4 8 6061 6065 O
an 9 11 6066 6068 O
oxygen 12 18 6069 6075 B-clinical_variable
saturation 19 29 6076 6086 I-clinical_variable
greater 30 37 6087 6094 O
than 38 42 6095 6099 O
or 43 45 6100 6102 O
equal 46 51 6103 6108 O
to 52 54 6109 6111 O
92 55 57 6112 6114 B-lower_bound
% 57 58 6114 6115 I-lower_bound
on 59 61 6116 6118 O
room 62 66 6119 6123 O
air 67 70 6124 6127 O

